An interventional study of Monitoring hemoglobin levels following anemia associated symptoms and Monitoring hemoglobin levels to detect anemia by screening of women at increased risk for post partum anemia in Postpartum Anemia, sponsored by HaEmek Medical Center, Israel. Completed at 1 site in Israel. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-07-14.
Sponsored by HaEmek Medical Center, Israel · Not applicable, Interventional, and Diagnostic
Anemia diagnosis by hemoglobin level monitoring in women after vaginal delivery by symptoms versus screening of women at increased risk for post-partum anemia.
Anemia is common following delivery. It is associated with some serious complications including increased risk for syncope and in severe cases even cardiogenic shock. Yet, anemia-associated symptoms might manifest relatively late after the patient have lost a fair amount of blood, which was not diagnosed early enough. To date, there are not acceptable guidelines for monitoring hemoglobin levels after delivery. Theoretically, there are 2 approaches for hemoglobin monitoring - one by taking hemoglobin levels in order to diagnose anemia in patients reporting anemia-associated symptoms. The other approach is by screening of women at increased risk for post-partum anemia. In the present study we aimed to compare those 2 approaches.
HaEmek Medical Center, Israel is the lead sponsor of 237 studies on the registry; 11 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Post partum anemia will be assessed by taking hemoglobin level following symptoms consistent with anemia, severe postpartum hemorrhage or hemoglobin level below 8 g/dL in the first 5 days following delivery
Other: Monitoring hemoglobin levels following anemia associated symptoms
Post partum anemia will be assessed by taking hemoglobin level in patients at increased risk to develop post-partum anemia in the first 5 days following delivery, defined as patients with initial (before or immediately after delivery) hemoglobin level of 10.5 g/dl or less regardless of symptoms, or in cases of severe post partum hemorrhage.
Other: Monitoring hemoglobin levels to detect anemia by screening of women at increased risk for post partum anemia
Post-partum anemia will be diagnosed after vaginal delivery by taking hemoglobin levels to patients with symptoms consistent with anemia, severe postpartum hemorrhage or hemoglobin level below 8 g/dL.
Post-partum anemia will be diagnosed after vaginal delivery by taking hemoglobin levels to high risk women for post-partum anemia, defined as hemoglobin levels of 10.5 g/dl or below around delivery, or severe postpartum hemorrhage with or without symptoms associated with anemia
The rate of patients diagnosed with anemia
Hemoglobin of 10 g/dl or below
Time frame: Up to 3 days postpartum
The rate of patients who received treatment with intravenous iron sucrose
Time frame: Up to 3 days postpartum
The rate of patients who received blood transfusion
Time frame: From delivery and up to 5 days
The rate of women with post-partum hemorrhage
Time frame: From delivery and up to 5 days
The rate of women who underwent uterine revision following delivery after their arrival to the maternity ward
Time frame: From delivery and up to 5 days
The rate of women who needed uterotonic agents after their arrival to the maternity ward
Time frame: From delivery and up to 5 days
The average blood tests number that was performed
Time frame: From delivery and up to 5 days
Minimal and average hemoglobin level
Time frame: From delivery and up to 5 days
The composite symptoms of anemia and functional capacity after 6 weeks postpartum as assessed by a questionnaire
Each question in the questionnaire will receive a score. The total score will be reported.
Time frame: 6 weeks postpartum
Hemoglobin level 6 weeks postpartum
Time frame: 6 weeks postpartum
This study is completed, as verified in May 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
HaEmek Medical Center, Israel →